[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 140
Citations 0
Comment & Response
April 2018

Methodological and Efficacy Issues in a Randomized Clinical Trial Investigating Vitreous Floater Treatment

Author Affiliations
  • 1VMR Institute for Vitreous Macula Retina, Huntington Beach, California
JAMA Ophthalmol. 2018;136(4):448. doi:10.1001/jamaophthalmol.2018.0212

To the Editor The negative impact of vitreous floaters is becoming increasingly apparent.1 Clinically relevant cases with abnormal vitreous structure and degraded contrast sensitivity function can be called vision-degrading vitreopathy to distinguish from insignificant cases. Increasingly, patients with this condition are being offered therapy by various means.